CVS Health Corp

CVS Health Corp Stock Forecast & Price Prediction

Live CVS Health Corp Stock (CVS) Price
$61.61

24

Ratings

  • Buy 15
  • Hold 9
  • Sell 0
Disclaimer : Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance. This information is for educational purposes only and should not be construed as advice to buy or sell any security.

Stock Price

$61.61

P/E Ratio

9.72

Volume Traded Today

$29.1M

Dividend

$0.665

52 Week High/low

83.25/52.77

CVS Health Corp Market Cap

$68.75B

๐Ÿ›‘ Alert: These ten stocks could have higher potential than $CVS ๐Ÿ›‘

Before you buy CVS you'll want to see this list of ten stocks that have huge potential. Want to see if CVS made the cut? Enter your email below

CVS Summary

The CVS Health Corp (CVS) share price is expected to increase by 9.38% over the next year. This is based on calculating the average 12-month share price estimate provided by 24 stock analysts who have covered CVS. Price targets range from $59 at the low end to $91.12 at the high end. The current analyst consensus for CVS is a buy. Please note analyst price targets are not guaranteed and could be missed completely.

CVS Analyst Ratings

CVS Health Corp has a total of 24 Wall St Analyst ratings. There are 15 buy ratings, 9 ratings, and 0 sell ratings. Since most analysts have a buy consensus rating, the expectation is that CVS Health Corp will outperform the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.

CVS stock forecast by analyst

These are the latest 20 analyst ratings of CVS.

Analyst/Firm

Rating

Price Target

Change

Date

Stephen Baxter
Wells Fargo

Equal-Weight

$60

Maintains

Nov 4, 2024
Ann Hynes
Mizuho

Outperform

$66

Maintains

Oct 24, 2024
Andrew Mok
Barclays

Overweight

$75

Maintains

Oct 23, 2024
David Macdonald
Truist Securities

Buy

$76

Maintains

Oct 11, 2024
Andrew Mok
Barclays

Overweight

$82

Upgrade

Oct 10, 2024
Elizabeth Anderson
Evercore ISI Group

Outperform

$75

Maintains

Oct 8, 2024
Charles Ryhee
TD Cowen

Buy

$85

Upgrade

Oct 4, 2024
Sarah James
Cantor Fitzgerald

Neutral

$62

Reiterates

Oct 1, 2024
Sarah James
Cantor Fitzgerald

Neutral

$62

Reiterates

Sep 16, 2024
Sarah James
Cantor Fitzgerald

Neutral

$62

Reiterates

Sep 10, 2024
Ben Hendrix
RBC Capital

Outperform

$68

Reiterates

Sep 4, 2024
Sarah James
Cantor Fitzgerald

Neutral

$62

Reiterates

Aug 19, 2024
Stephen Baxter
Wells Fargo

Equal-Weight

$61

Maintains

Aug 12, 2024
George Hill
Deutsche Bank

Hold

$63

Maintains

Aug 9, 2024
Elizabeth Anderson
Evercore ISI Group

Outperform

$62

Maintains

Aug 8, 2024
Andrew Mok
Barclays

Equal-Weight

$63

Maintains

Aug 8, 2024
Sarah James
Cantor Fitzgerald

Neutral

$62

Maintains

Aug 8, 2024
Sarah James
Cantor Fitzgerald

Neutral

$58

Reiterates

Jul 23, 2024
Sarah James
Cantor Fitzgerald

Neutral

$58

Reiterates

Jun 12, 2024
Lisa Gill
JP Morgan

Overweight

$86

Maintains

May 30, 2024

CVS Company Information

What They Do: Provides comprehensive health solutions in the U.S.

Business Model: The company operates through three segments: Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness. It generates revenue by offering health insurance products, pharmacy benefit management solutions, and selling prescription drugs along with consumer health products. Its diverse client base includes employers, individuals, and government entities, allowing it to serve multiple markets within the healthcare industry.

Other Information: CVS Health Corporation, formerly known as CVS Caremark Corporation, was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island. The company's extensive network includes retail pharmacies, online platforms, and specialty pharmacy services, positioning it as a significant player in the healthcare sector.
CVS
CVS Health Corp (CVS)

When did it IPO

1984

Staff Count

219,000

Country

United States

Sector/Industry

Healthcare/Healthcare Plans

CEO

Ms. Karen Sue Lynch

Market Cap

$68.75B

CVS Health Corp (CVS) Financial Data

In 2023, CVS generated $357.78B in revenue, which was a increase of 10.95% from the previous year. This can be seen as a signal that CVS's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.

Revenue From 2020

$268.71B

Revenue From 2021

$292.11B

8.71 %
From Previous Year

Revenue From 2022

$322.47B

10.39 %
From Previous Year

Revenue From 2023

$357.78B

10.95 %
From Previous Year
  • Revenue TTM $361.85B
  • Operating Margin TTM 3.0%
  • Gross profit TTM $54.43B
  • Return on assets TTM 2.9%
  • Return on equity TTM 9.7%
  • Profit Margin 2.0%
  • Book Value Per Share 59.66%
  • Market capitalisation $68.75B
  • Revenue for 2021 $292.11B
  • Revenue for 2022 $322.47B
  • Revenue for 2023 $357.78B
  • EPS this year (TTM) $5.62

CVS Health Corp (CVS) Latest News

News Image

Wed, 06 Nov 2024

Sentiment - NEUTRAL

Source - Market Watch

Summary - CVS's stock increased following higher-than-expected revenue, although profits fell short due to a significant charge related to premium deficiency reserves.

Why It Matters - CVS's revenue beat expectations, indicating strong demand, but profit miss due to reserves may signal future challenges. This mixed performance affects investor confidence and stock valuation.

News Image

Wed, 06 Nov 2024

Sentiment - NEGATIVE

Source - CNBC

Summary - CVS Health's Q3 results were mixed due to rising medical costs impacting profits. The company has not provided a formal outlook due to ongoing elevated costs.

Why It Matters - CVS Health's mixed results and lack of guidance signal potential ongoing financial challenges, impacting investor confidence and stock performance due to rising medical costs.

News Image

Wed, 06 Nov 2024

Sentiment - POSITIVE

Source - CNBC Television

Summary - CVS has announced new developments, as reported by CNBC's Bertha Coombs. Further details on the impact of these changes on the companyโ€™s performance may be relevant for investors.

Why It Matters - CVS news can impact stock performance, business strategy, and competitive positioning in the healthcare sector, influencing investor sentiment and market movements.

News Image

Wed, 06 Nov 2024

Sentiment - POSITIVE

Source - Investopedia

Summary - CVS Health shares rose after the company reported better-than-expected results and CEO David Joyner announced leadership changes to improve performance.

Why It Matters - CVS's strong earnings and leadership changes signal potential turnaround strategies, boosting investor confidence and suggesting improved future performance.

News Image

Wed, 06 Nov 2024

Sentiment - NEUTRAL

Source - Benzinga

Summary - U.S. stocks rose mid-session Wednesday, with the Nasdaq Composite up over 2%.

Why It Matters - Rising U.S. stock prices, particularly a 2% gain in the Nasdaq, indicate investor optimism and potential market momentum, which can drive further investment and influence trading strategies.

News Image

Wed, 06 Nov 2024

Sentiment - NEUTRAL

Source - Reuters

Summary - CVS Health appointed Steve Nelson, ex-UnitedHealth head, to lead Aetna amid rising medical costs, which led to a preannounced earnings miss for the third quarter.

Why It Matters - Steve Nelson's appointment at Aetna signals a strategic shift to address rising medical costs, impacting CVS's profitability and investor confidence following a recent earnings miss.

...

CVS Frequently asked questions

The highest forecasted price for CVS is $91.12 from at .

The lowest forecasted price for CVS is $59 from from JP Morgan

The CVS analyst ratings consensus are 15 buy ratings, 9 hold ratings, and 0 sell ratings.